Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors

摘要：
本文献已被 ScienceDirect 等数据库收录！